The PBAC may be unconcerned about some unimplemented recommendations but it could also 'remake' outcomes to make a listing possible, albeit after two years. …
Could the 'review' process resolve disputes and not just rescind outcomes?
June 29, 2020 Latest News
Latest Video
New Stories
-
COVID-19: Pfizer the latest to announce positive vaccine data
July 3, 2020 - - Latest News -
COVID-19: Positive news on Affinity Biosciences antibodies
July 3, 2020 - - Latest News -
Funding for new Sanofi haemophilia treatments
July 3, 2020 - - Latest News -
COVID-19: New data reveals slump in new cancer treatment
July 2, 2020 - - Latest News -
COVID-19: FDA will not compromise standards on vaccine approval
July 2, 2020 - - Latest News -
Roche unveils new organisational 'system'
July 2, 2020 - - Latest News -
Mylan shareholders approve merger with Pfizer's Upjohn
July 2, 2020 - - Latest News